双膦酸盐在前列腺癌中的应用：现状
Use of bisphosphonates in prostate cancer: Current status.
作者信息
Nayyar Rishi, Gupta Narmada P
机构信息
Department of Urology, All India Institute of Medical Sciences, New Delhi - 110 029, India.
出版信息
Indian J Urol. 2007 Jan;23(1):51-4. doi: 10.4103/0970-1591.30267.
Abstract
Bisphosphonates are a relatively newer class of drugs which have been used for the prevention of skeletal related complications of age related osteoporosis or metastatic disease from carcinoma breast or multiple myeloma. Their role in the management of prostate cancer is still under evolution. We hereby review the ongoing and some published randomized trials to define the role of bisphosphonates in various stages of prostate cancer.
摘要
双膦酸盐是一类相对较新的药物，已被用于预防与年龄相关的骨质疏松症或乳腺癌或多发性骨髓瘤转移疾病的骨骼相关并发症。它们在前列腺癌治疗中的作用仍在不断演变。我们在此回顾正在进行的以及一些已发表的随机试验，以确定双膦酸盐在前列腺癌各个阶段的作用。
相似文献
1
Use of bisphosphonates in prostate cancer: Current status.双膦酸盐在前列腺癌中的应用：现状
Indian J Urol. 2007 Jan;23(1):51-4. doi: 10.4103/0970-1591.30267.
2
Bisphosphonates for advanced prostate cancer.双膦酸盐用于晚期前列腺癌。
Cochrane Database Syst Rev. 2006 Oct 18(4):CD006250. doi: 10.1002/14651858.CD006250.
3
Bisphosphonates in the prevention and treatment of bone metastases.双膦酸盐在骨转移瘤防治中的应用
Oncology (Williston Park). 2003 Sep;17(9):1261-70; discussion 1270-2, 1277-8, 1280.
4
Bisphosphonates for breast cancer.用于乳腺癌的双膦酸盐类药物。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD003474. doi: 10.1002/14651858.CD003474.pub2.
5
Bisphosphonates for cancer patients: why, how, and when?用于癌症患者的双膦酸盐：为何使用、如何使用以及何时使用？
Support Care Cancer. 2002 Jul;10(5):399-407. doi: 10.1007/s005200100292. Epub 2001 Oct 19.
6
Bisphosphonates for breast cancer.用于乳腺癌的双膦酸盐类药物。
Cochrane Database Syst Rev. 2002(1):CD003474. doi: 10.1002/14651858.CD003474.
7
The role of bisphosphonates in breast and prostate cancers.双膦酸盐在乳腺癌和前列腺癌中的作用。
Endocr Relat Cancer. 2004 Jun;11(2):207-24. doi: 10.1677/erc.0.0110207.
8
Bisphosphonates for malignancy-related bone disease: current status, future developments.双膦酸盐用于恶性肿瘤相关骨病：现状与未来发展
Support Care Cancer. 2006 May;14(5):408-18. doi: 10.1007/s00520-005-0913-5. Epub 2006 Feb 1.
9
Clinical value of bisphosphonates in cancer therapy.双膦酸盐在癌症治疗中的临床价值。
Anticancer Res. 2007 Jul-Aug;27(4A):1759-68.
10
The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials.双膦酸盐在疼痛性转移性骨病治疗中的作用：III期试验综述
Pain. 1998 Dec;78(3):157-169. doi: 10.1016/S0304-3959(98)00135-3.
本文引用的文献
1
The role of bisphosphonates in preventing skeletal complications of hormonal therapy.双膦酸盐在预防激素治疗的骨骼并发症中的作用。
Urol Clin North Am. 2006 May;33(2):191-9, vi. doi: 10.1016/j.ucl.2005.12.009.
2
Cancer statistics, 2006.2006年癌症统计数据。
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30. doi: 10.3322/canjclin.56.2.106.
3
The role of bisphosphonates in the treatment of prostate cancer.双膦酸盐在前列腺癌治疗中的作用。
BJU Int. 2005 May;95(7):935-8. doi: 10.1111/j.1464-410X.2005.05441.x.
4
Risk of fracture after androgen deprivation for prostate cancer.前列腺癌雄激素剥夺治疗后的骨折风险。
N Engl J Med. 2005 Jan 13;352(2):154-64. doi: 10.1056/NEJMoa041943.
5
Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer.奈立膦酸盐可预防接受前列腺癌雄激素剥夺治疗患者的骨质流失。
J Bone Miner Res. 2004 Nov;19(11):1766-70. doi: 10.1359/JBMR.040813. Epub 2004 Aug 23.
6
Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancer.多西他赛与唑来膦酸用于转移性激素难治性前列腺癌患者的研究
BJU Int. 2004 Sep;94(4):524-7. doi: 10.1111/j.1464-4096.2004.04919.x.
7
Osteoporosis: a disease in men.骨质疏松症：男性中的一种疾病。
Clin Orthop Relat Res. 2004 Aug(425):143-51.
8
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.唑来膦酸预防转移性激素难治性前列腺癌患者骨骼并发症的长期疗效。
J Natl Cancer Inst. 2004 Jun 2;96(11):879-82. doi: 10.1093/jnci/djh141.
9
The impact of osteoporosis in men treated for prostate cancer.骨质疏松症对接受前列腺癌治疗的男性的影响。
Urol Clin North Am. 2004 May;31(2):313-9. doi: 10.1016/j.ucl.2004.02.002.
10
Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies.接受雄激素剥夺治疗的前列腺癌男性患者的骨质疏松症：诊断和治疗建议
Cancer. 2004 Mar 1;100(5):892-9. doi: 10.1002/cncr.20056.
Zotero 插件